Legal & General Group’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.4K | Buy |
2,954
+2,922
| +9,131% | +$29.1K | ﹤0.01% | 2859 |
|
|
2025
Q1 | $2.84K | Hold |
32
| – | – | ﹤0.01% | 3332 |
|
|
2024
Q4 | $2.98K | Hold |
32
| – | – | ﹤0.01% | 3369 |
|
|
2024
Q3 | $2.36K | Hold |
32
| – | – | ﹤0.01% | 3396 |
|
|
2024
Q2 | $1.85K | Sell |
32
-2
| -6% | -$116 | ﹤0.01% | 3407 |
|
|
2024
Q1 | $34.8K | Sell |
34
-14
| -29% | -$14.3K | ﹤0.01% | 2824 |
|
|
2023
Q4 | $37.7K | Sell |
48
-172
| -78% | -$135K | ﹤0.01% | 2847 |
|
|
2023
Q3 | $104K | Buy |
220
+55
| +33% | +$26.1K | ﹤0.01% | 2825 |
|
|
2023
Q2 | $99K | Buy |
165
+67
| +68% | +$40.2K | ﹤0.01% | 2833 |
|
|
2023
Q1 | $69.2K | Buy |
98
+6
| +7% | +$4.24K | ﹤0.01% | 2828 |
|
|
2022
Q4 | $94.8K | Buy |
92
+70
| +318% | +$72.1K | ﹤0.01% | 2832 |
|
|
2022
Q3 | $13K | Buy |
22
+10
| +83% | +$5.91K | ﹤0.01% | 3294 |
|
|
2022
Q2 | $6K | Sell |
12
-26
| -68% | -$13K | ﹤0.01% | 3428 |
|
|
2022
Q1 | $25K | Buy |
38
+11
| +41% | +$7.24K | ﹤0.01% | 3172 |
|
|
2021
Q4 | $11K | Hold |
27
| – | – | ﹤0.01% | 3435 |
|
|
2021
Q3 | $20K | Buy |
+27
| New | +$20K | ﹤0.01% | 3269 |
|